Built by physician-scientists. Engineered for sovereign-scale impact.
GenREY is a physician-scientist-led biotechnology platform created to translate advanced regenerative science into real-world clinical, commercial and sovereign healthcare impact.
Founded by a multidisciplinary team of MDs, PhDs, scientists and operators, GenREY operates from a U.S. base — Houston / Texas — with strategic expansion across the GCC including Saudi Arabia, Qatar and the UAE. Our work spans seven active R&D programs in regenerative medicine, organ bioengineering, rare-disease intelligence and precision therapeutics.
Unlike conventional biotech startups, GenREY is structured as a sovereign-grade platform — meaning we are equally comfortable operating inside an academic medical centre, a national research institute, or a Vision-2030-aligned ministry programme. Every protocol, IP filing and commercialisation pathway is designed to be portable across our dual-hub geography.
Our co-founders include an O-1A / EB-1A Extraordinary-Ability physician-scientist with 20+ peer-reviewed PubMed publications, a translational COO with deep U.S.–GCC operational expertise, and a CSO bridging regenerative biology and translational science. We collaborate with surgeons, bioengineers, omics scientists and policy advisors who have shipped real medicine, not slide decks.
A physician-scientist-led platform translating regenerative science into clinical, commercial and sovereign healthcare impact.
GenREY is built by a team of MDs, PhDs, scientists and business leaders — a U.S.-based platform with active GCC expansion across Saudi Arabia, Qatar and the UAE — connecting Houston / Texas innovation with Vision-2030 life-sciences leadership.
We engineer where research meets commercialization: device platforms, regenerative formulations, sovereign data infrastructure and translational programs designed for national capability development.
Our north star is simple — translate regenerative biology into technologies that restore, rebuild and extend human health, while standing up the sovereign biotech capabilities the next decade demands.
“GenREY is built where medicine, biology, robotics and sovereign capability meet — translating physician-led science into national-scale impact across the U.S.-GCC corridor.”
Where to next?
Continue exploring how GenREY translates science into sovereign-scale impact.